Appropriate health care in Duchenne muscular dystrophy (DMD) can markedly increase quality of sleep and quality of life according to a study presenting the case of two women who are manifesting carriers of the disease.
News
A researcher at the University of Texas Southwestern Medical Center has been awarded a $250,000 grant to study CRISPR/Cas9 technology‘s potential to treat Duchenne muscular dystrophy (DMD). CRISPR/Cas9 allows researchers to add, remove, or change sections of the DNA sequence. Parent Project Muscular Dystrophy (PPMD) will give the…
Bone fragility is a serious consequence of long-term corticosteroid treatment — the main option for Duchenne muscular dystrophy (DMD) — but an analysis found that there are no high-quality studies on how to improve patients’ bone health. The analysis, “Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent…
News
More Research Needed to Understand Physiological Responses to Assistive Technology, Study Finds
People with Duchenne muscular dystrophy have a lower heart rate variability than healthy people — an abnormality that worsened after completing a computer task. Since low heart rate variability has been reported as a risk factor for heart failure, the finding indicates that more research is needed to better understand the…
The binding of two proteins called titin and α-actinin ensures that muscles are not ripped apart when they are forced to stretch, according to new research. Scientists believe the identification and study of this protein interaction may offer new possibilities for the treatment of diseases such as muscular dystrophy. The…
News
Physical Activity Encouraged for Duchenne MD Patients Who Are Less Active Than Peers, Study Finds
Engagement in physical activity can increase the sense of self-worth and belonging to a group, and can help form peer relationships in children with Duchenne muscular dystrophy (MD), according to a study published in the Journal of Child Neurology.
A Duchenne muscular dystrophy (DMD) patient who is now in his 50s gained the notice of researchers, who say his case could illustrate the benefits of noninvasive mechanical ventilation in patients with well-maintained cardiac function. It is the first report of a patient living into his sixth decade. The report, “New Survival…
Yale New Haven Children’s Hospital’s (YNHCH) Muscular Dystrophy Program has been named a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), a nonprofit organization dedicated to ending Duchenne muscular dystrophy (DMD). PPMD’s Certified Duchenne Care Center Program, which was started in 2014, supports standardized, comprehensive…
The New Jersey Institute of Technology (NJIT) and Talem Technologies will explore the potential of robotic technology to assist people living with Duchenne muscular dystrophy (DMD), using a $600,000 grant awarded by Parent Project Muscular Dystrophy (PPMD). The two-year project is titled “Investigation of the Community Use…
The European Commission has granted Orphan Drug Designation to Benitec Biopharma’s BB-301, an investigational treatment for oculopharyngeal muscular dystrophy (OPMD). The decision represents a major advance for OPMD, a rare congenital myopathy, for which the currently used therapeutic strategies involve repetitive surgical interventions that have limited effectiveness. Orphan Drug…
Recent Posts
- MDA 2026: More dietary protein linked to better lower limb function in MD
- ‘The Wonder Years’ were the ‘worry years’ before my MD diagnosis
- What’s on my wish list for my family’s Duchenne dream home
- DMD gene therapy can repair muscle fibers but fails to halt tissue scarring
- How AI can support my daily life with Duchenne muscular dystrophy